Quick Internal Medicine Topics

Similar documents
The Shifting Federal Regulation of Cannabis Products

A look at Marijuana in 2014

Northern California Chapter, ACP Update In Medicine

TREATMENT OF TOBACCO USE DISORDERS E-CIGS & APPS

I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people

The Voice of Local Public Health in New York State. May 12, 2014

Pharmacotherapy for Tobacco Dependence Treatment

Dr. Hagit Marchaim, Regulatory Affairs & Drug Development Consulting - HMC

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system

Smoking Cessation Strategies in 2017

A GUIDE TO TALKING WITH YOUR DOCTOR ABOUT EPIDIOLEX

Medical Cannabis MATT WEBSTER DO, MS

CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS

The Latest on Vaping Among U.S. Teens

Smoking, e-cigs and reduced risk products. Dr John Schoonbee, IMS November 2017

Medical Marijuana Update Chris Belletieri, DO

4/15/2019. US States with Marijuana Laws in Have ACOG and SMFM taken notice? THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION

Georgia Cannabidiol Study Frequently Asked Questions

Might Smoking Rates go up in Flames? Dr John Schoonbee, Chief Medical Officer, Swiss Re

Medical Marijuana: The Move to Schedule II

UNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products

Electronic Nicotine Delivery Systems

Global Legal Cannabis Market: Size, Trends & Forecasts ( ) September 2018

CDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only

Welcome Superheros! YOUR. Winter Awareness Workshop 2017 BE A HERO IN COMMUNITY!

EMERGING ISSUES IN SMOKING CESSATION

James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada

Is Vaping a Valid Strategy for Smoking Cessation? Myths and Facts Jaspreet S. Brar. MD, PhD Community Care Behavioral Health Organization

The Evidence on E-cigarettes: Evaluating What We Have and Identifying What We Need

The products being taken by children with epilepsy are not the equivalent of the marijuana widely used for recreational purposes.

Treating Tobacco Use:

AGENDA. 9:00 Sign-in and introductions 9:15 Marijuana 10:30 Break 10:45 Opioid Prevention 11:30 Discussion & Wrap-Up

PEDIATRIC EXPOSURE PREVENTION

Changing the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol (THC), Cannabidiol and Combinations to Promote Research

TOBACCO PLAYBOOK DÉJÀ VU: E-CIGARETTES MICHIGAN CANCER CONSORTIUM MARCH 26, 2014

Clearing the Air Vaping Prevention - Northwood HS

Is there a role for medical marijuana in the management of IBD? Jami A. Kinnucan, MD Division of Gastroenterology University of Michigan Hospital

CBD & Hemp Oil: Cannabis, Cannabinoids And The Benefits Of Medical Marijuana By Aaron Hammond READ ONLINE

CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE

Varenicline and cardiovascular and neuropsychiatric events: Do Benefits outweigh risks?

Horace Greeley High School Parent Presentation Vaping, E-cigs and the Health of Our Youth. Richard Stumacher, MD, FCCP January 18, 2018

The Modified Risk Products. or Protectionism?

AN UPDATE ON FDA S COMPREHENSIVE PLAN ON TOBACCO AND NICOTINE

CBD and Your Health.

Medicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer

THE COMPLETE CBD GUIDE

Beginner s Guide to CBD OIL

Clear the Vapor: FILTERING FACTS FROM MYTHS ON VAPING, JUULING & CANNABIS

ELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE?

Communicating the Risk of Nicotine Delivery Products

Marijuana. DATE: February 21, 2017 PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine

Non-Industry Voices on Tobacco Harm Reduction and Vaping Products

Flavors Hook Kids. The Tobacco Industry s Kids Menu MARIPOSA COUNTY HEALTH DEPARTMENT

MARIJUANA & THE EFFECTS ON THE BRAIN

MDQuit Best Practices Conference January 26, Presented by William C. Tilburg Deputy Director

E.cigarettes. An alternative to a uniquely deadly product that kills one in two of its regular users? Paul Lambert Public Health, Leeds City Council

INTRODUCTION WHAT IS MARIJUANA 2/28/2018

PEDIATRIC EXPOSURE PREVENTION CLINICAL GUIDANCE FOR COLORADO HEALTH CARE PROVIDERS

Medical Marijuana. Navigating Medical Marijuana in Workers Compensation

Learning Objectives 4/3/2018 UP IN SMOKE: NAVIGATING THE CHANGING LANDSCAPE OF SMOKING CESSATION BACKGROUND

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Cannabis in the treatment of Autism:

Slide 1. Slide 2. Slide 3. Reducing Tobacco Use and Nicotine Dependence in Clinical Settings. Goals for Today

Acknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making

Marijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US

Electronic Nicotine and Non Nicotine Delivery Systems (ENDS)

Federal Law: Marijuana

History Of Medical Cannabis

Use of e-cigarettes (vapourisers) among adults in Great Britain

9/28/2015. Support. R01CA A1 Intervening with smoking parents of inpatients to reduce

Frequently Asked Questions

Prevent disease Protect from injury Promote healthy lifestyles

00:08 For decades our scientists have endeavoured to reduce the risks of tobacco use and continue to do so today. 00:15

Medical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.

WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis. Expert Peer Review 2

National Conference of State Legislatures Legislative Summit: Clearing the Air About E-Cigarettes

/msdcenter. msdcenter. Tomorrow in Austin and via Livestream: msdcenter.org

Smoking Cessation: A readily modifiable risk factor

Cannabinoids: access and symptom management in cancer

E-Cigarettes and Vapes

Cannabis and cannabinoids for medicinal purposes

Investigational Pharmacy Cannabidiol treatment in Epilepsy

SECTION V: EMPLOYEES POLICY 5375 MEDICAL MARIJUANA, HEMP & CANNABIDIOL (CBD)

Medicinal cannabinoids: current regulations for prescribing

Presented by: The Association of State and Territorial Health Officials (ASTHO) January 29 th, :00-3:30pm ET

Organization: NAMI Minnesota Request ID: Program Title: Reducing Smoking Among People with Mental Illnesses

TOBACCO PLAYBOOK DÉJÀ VU: E-CIGARETTES

Tobacco Cessation, E- Cigarettes and Hookahs

How to Regulate E-Cigarettes? Are we asking the right questions?

Final Frequencies (n=1,000) NATIONAL HEALTH SURVEY The Mellman Group & Public Opinion Strategies April 11, 2017

Electronic Nicotine Delivery Systems: Patterns of Use and Disparities

Dual Use: If Electronic Cigarettes are so good, why are there so few exclusive users?. Jonathan Foulds, PhD

American Vaping Association

CANNABIS FOR THE RHEUMATOLOGIST

Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD

The Cannabis Legal Landscape Today. Erika Lietzan University of Missouri School of Law November 2018

Daniel Fabricant, Ph.D

Marijuana in Pregnancy

Transcription:

Quick Internal Medicine Topics David R. Hilden, MD MPH FACP Hennepin Healthcare Associate Professor of Medicine University of Minnesota Medical School

I have no financial disclosures or conflicts of interest to report

Quick Internal Medicine Topics Electronic cigarettes Aspirin for primary prevention of heart disease in elderly CBD oil How to get Fido on the plane at MSP

Topic 1: E-cigarettes 1. Are e-cigs safer than cigarettes and do they assist in smoking cessation? 2. What about the kids? Are e-cigs a potentially safer product for adolescents and young adults? Is there evidence for any of this?

Electronic cigarettes and tobacco Adolescents - current use (high school) Any tobacco product 19.6% (2011 = 24.2%) E-cigarettes 11.7% (2011 = 1.5%) Cigars 7.7% Cigarettes 7.6% (2011 = 15.8%) Smokeless tobacco 5.5% Adults current use Any tobacco product 10.2 27.7% (CA, WV) Cigarettes: 8.0-21.7% (UT, WV) E-cigarette 1.3 4.4% (DE, WY) Tobacco Product Use Among Middle and High School Students United States, 2011 2017 Weekly / June 8, 2018 / 67(22);629 633 State-Specific Prevalence of Tobacco Product Use Among Adults United States, 2014 2015 Weekly / January 26, 2018 / 67(3);97 102

Components of an electronic cigarette. Jamie Hartmann-Boyce et al. BMJ 2018;360:bmj.j5543 2018 by British Medical Journal Publishing Group

E-cigarettes and safety What is known: E-cig nicotine levels can equal cigarette levels Carcinogen and toxin levels are lower E-cigs are a safer alternative to combustible tobacco But long-term evidence is lacking Consensus opinion: perhaps only 5% as risky E-cigs may help people quit, but data are poor RCT: 9% quit 6-12 month quite rate vs 4% control Shahab L et al. Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-sectional Study. Ann Intern Med. ;166:390 400. doi: 10.7326/M16-1107 Hartmann-Boyce J et al Electronic Cigarettes for Smoking Cessation, BMJ 2018;360:j5543

Safer for teens? Major manufacturer website: *** was created to be a satisfying alternative to cigarettes. Learn about our mission to improve the lives of the world's one billion adult smokers. 90% of e-cigs contain flavors that adolescents favor: mango, mint, fruit medley, cappuccino, strawberry Do they become cigarette smokers? Answer: 3.5x higher risk of initiating cigarettes (23.2% vs 7.2%) Soneji S, Barrington-Trimis JL, Wills TA, et al. Association Between Initial Use of e-cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults A Systematic Review and Meta-analysis. JAMA Pediatr. 2017;171(8):788 797. doi:10.1001/jamapediatrics.2017.1488

Tips to tell your patients Smoking is deadly, and e-cigs may help you quit E-cigarette are very likely safer than smoking, though we don t have long-term safety data Other smoking cessation techniques (meds, NRT) are known to be safe and effective E-cigs should only be used in people who smoke cigarettes as an aid to quitting Kids who vape are at higher risk for starting smoking

Topic 2: Aspirin for primary prevention Should healthy elderly people take aspirin to extend healthy lifespan?

ASPREE study ASPREE published NEJM on September 16, 1028 Largest aspirin primary prevention trial ever done in elderly Randomized, double-blind controlled trial ~19,000 participants, 34 sites in Australia and US over 5 years Funded by US and Australia governments Anne Murray, MD US Principal Investigator, ASPREE trial Hennepin Healthcare / Univ of Minnesota

Effect of Aspirin on Disability-free Survival in the Healthy Elderly McNeil J.J., Woods R.L., Nelson M.R., et al. 10.1056/NEJMoa1800722

ASPREE study Primary outcome (composite death, dementia or disability) No benefit with aspirin 8 secondary endpoints Death from any cause (cancer = ~50%) Dementia Permanent physical disability CV disease, including stroke Cancer Mild cognitive impairment Depression Major hemorrhage No benefit No benefit No benefit No benefit

ASPREE study For healthy people >70 years old (> 65 years old for US blacks & Latinos) Bottom line: there is no benefit in taking daily aspirin Applies to healthy people: No significant heart or cerebrovascular disease No venous thromboembolic disease No dementia The risk of major bleeding is 38% higher in ASA patients (3.8% vs 2.8%, p<0.001) Trial stopped a few months early due to lack of benefit and increased risk

Take home point Daily low dose aspirin does not prolong disability-free survival in healthy elderly people Note: Should you tell those already taking ASA to stop? This trial can t answer that

Read the ASPREE trials McNeil JJ, et al Effect of Aspirin on Disability-free Survival in the Healthy Elderly, NEJM, September 16, 2018 https://www-nejm-org.ezp3.lib.umn.edu/doi/full/10.1056/nejmoa1800722

Topic 3: Cannabidiol (CBD) Is CBD beneficial for any health condition and is it safe?

Cannabidiol (CBD) Major substances in cannabis (>100 in total) Tetrahydrocannabinol (THC) = Psychoactive Many studies have shown benefits for seizures, anorexia, nausea, pain By de:benutzer:michael_w [GFDL (http://www.gnu.org/copyleft/fdl.html) or CC-BY-SA-3.0 (http://creativecommons.org/licenses/by -sa/3.0/)], via Wikimedia Commons Cannabidiol (CBD) = NOT psychoactive = no high Lack of research Was thought to be inactive

CBD: what we know Regulatory DEA moved from Schedule 1 to Schedule 5 September 2018 for specific fixed-dose formulation The raw hemp/cannabis is still Schedule 1 FDA-approved June 2018 for single indication: seizures due to Lennox-Gastaut Syndrome and Dravet Syndrome Murky legality (Federal vs state laws) May not be called a dietary or nutritional supplement, it is a drug Low abuse potential Even among polydrug users https://www.dea.gov/press-releases/2018/09/27/fda-approved-drug-epidiolex-placed-schedule-v-controlled-substance-act Schoedel KA et al Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial. Epilepsy Behav. 2018 Oct 1;88:162-171

CBD uses: what is claimed Seizures (strongest evidence) Anxiety, esp social anxiety (some evidence) Inflammation (some evidence) The rest of the potential uses do not have strong human studies Depression, pain, nausea and vomiting, sleep disorders, acne and other skin conditions, multiple sclerosis, arthritis, fibromyalgia, cancer symptoms...

CBD uses: what is not known Long-term effects Efficacy / benefit in high-quality human trials for any of the claimed conditions Where the regulatory environment is going The actual CBD content of products on the market (next slide) Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R. Labeling Accuracy of Cannabidiol Extracts Sold Online. JAMA. 2017;318(17):1708 1709. doi:10.1001/jama.2017.11909

From: Labeling Accuracy of Cannabidiol Extracts Sold Online JAMA. 2017;318(17):1708-1709. doi:10.1001/jama.2017.11909 Table Title: Label Accuracy by Cannabidiol Extract Type Date of download: 10/8/2018 Copyright 2017 American Medical Association. All Rights Reserved.

Take home points CBD oil shows promise treating a variety of conditions, but data for efficacy and long-term safety is lacking. Few adverse effects and low abuse potential are encouraging. Marketing and manufacturing of CBD products is unregulated and potentially of concern for our patients

Topic 4: Getting Fido on the plane at MSP What are emotional support animals (ESA) and what is the clinician s role in authorizing air travel for ESAs? Photo: Megan Peabody via Instagram hamlet_the_beach_hog. Used by permission.

Animals in mental health Animal-assisted therapy Accepted as having benefit in clinical & institutional settings. Ex: Dog assisted therapy reduces symptoms of depression in institutionalized elderly Service-animals, mostly dogs and miniature horses... service animal includes individually trained animals that do work or perform tasks for the benefit of individuals with disabilities, including psychiatric, cognitive, and mental disabilities. (ada.gov) By Pete Markham from Loretto, USA (Big and Little) [CC BY-SA 2.0 (https://creativecommons.org/licenses/bysa/2.0)], via Wikimedia Commons for public use. Ambrosi, C. et al (2018), Randomized controlled study on the effectiveness of animal assisted therapy on depression, anxiety, and illness perception in institutionalized elderly. Psychogeriatrics.

Emotional support animals Potentially competing interests: Legitimate ESA needs Bunny for child with autism Variety of animals for anxious flyers Pet-handling fees (MSP-LAX for 40# pig = $456) Comfort and safety of other travelers Photo: dexterthepeacock viajetsettv

Here s what you need to do... Source: Delta Airlines via delta.com

And if that fails... just get this guy to do it Source: Delta Airlines via delta.com

Thank you! David.Hilden@hcmed.org